Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-09-16 Sale |
2020-09-18 5:19 pm |
FIBROGEN INC | FGEN | Yu K Peony Chief Medical Officer |
3,351 | $44.01 | $147,478 | 198,934 (Direct) |
View |
| 2020-09-15 Sale |
2020-09-17 6:03 pm |
FIBROGEN INC | FGEN | Cotroneo Pat SVP, Finance and CFO |
3,070 | $43.63 | $133,944 | 272,226 (Direct) |
View |
| 2020-09-03 Sale |
2020-09-04 4:33 pm |
FIBROGEN INC | FGEN | Yu K Peony Chief Medical Officer |
10,000 | $50.89 | $508,900 | 248,076 (Direct) |
View |
| 2020-09-03 Sale |
2020-09-04 4:30 pm |
FIBROGEN INC | FGEN | Cotroneo Pat SVP, Finance and CFO |
15,004 | $50.91 | $763,854 | 324,507 (Direct) |
View |
| 2020-08-07 Sale |
2020-08-11 4:34 pm |
FIBROGEN INC | FGEN | Cotroneo Pat SVP, Finance and CFO |
22,554 | $48 | $1,082,592 | 293,452 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2020-12-03 6:41 pm |
N/A N/A |
FIBROGEN INC | FGEN | Eisner Mark Incoming Chief Medical Officer |
0 | $0 | 0 (Direct) |
View |
| 2020-11-17 Exercise |
2020-11-19 4:52 pm |
N/A N/A |
FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety |
7,082 | $14.57 | 134,495 (Direct) |
View |
| 2020-11-17 Exercise |
2020-11-19 4:52 pm |
N/A 2024-03-19 |
FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety |
7,082 | $0 | 134,495 (Direct) |
View |
| 2020-09-08 Tax Withholding |
2020-09-10 7:36 pm |
N/A N/A |
FIBROGEN INC | FGEN | Yu K Peony Chief Medical Officer |
3,291 | $42.16 | 202,285 (Direct) |
View |
| 2020-09-08 Tax Withholding |
2020-09-10 7:32 pm |
N/A N/A |
FIBROGEN INC | FGEN | Kouchakji Elias SVP, Clinical Dev, Drug Safety |
2,728 | $42.16 | 127,413 (Direct) |
View |
| 2020-09-08 Tax Withholding |
2020-09-10 7:30 pm |
N/A N/A |
FIBROGEN INC | FGEN | Cotroneo Pat SVP, Finance and CFO |
3,014 | $42.16 | 275,296 (Direct) |
View |
| 2020-09-08 Tax Withholding |
2020-09-10 7:28 pm |
N/A N/A |
FIBROGEN INC | FGEN | Chung Christine SVP, China Operations |
3,038 | $42.16 | 153,615 (Direct) |
View |
| 2020-09-03 Exercise |
2020-09-04 4:33 pm |
N/A N/A |
FIBROGEN INC | FGEN | Yu K Peony Chief Medical Officer |
10,000 | $18 | 248,076 (Direct) |
View |
| 2020-09-03 Exercise |
2020-09-04 4:33 pm |
N/A 2024-11-13 |
FIBROGEN INC | FGEN | Yu K Peony Chief Medical Officer |
10,000 | $0 | 248,076 (Direct) |
View |
| 2020-09-03 Exercise |
2020-09-04 4:30 pm |
N/A N/A |
FIBROGEN INC | FGEN | Cotroneo Pat SVP, Finance and CFO |
637 | $29.66 | 324,507 (Direct) |
View |
| 2020-09-03 Exercise |
2020-09-04 4:30 pm |
N/A 2025-03-04 |
FIBROGEN INC | FGEN | Cotroneo Pat SVP, Finance and CFO |
15,004 | $0 | 324,507 (Direct) |
View |
| 2020-09-03 Exercise |
2020-09-04 4:30 pm |
N/A N/A |
FIBROGEN INC | FGEN | Cotroneo Pat SVP, Finance and CFO |
5,696 | $19.39 | 324,507 (Direct) |
View |
| 2020-09-03 Exercise |
2020-09-04 4:30 pm |
N/A N/A |
FIBROGEN INC | FGEN | Cotroneo Pat SVP, Finance and CFO |
8,671 | $25.4 | 324,507 (Direct) |
View |
| 2020-08-20 Exercise |
2020-08-21 5:58 pm |
N/A 2022-06-27 |
FIBROGEN INC | FGEN | Schoeneck James A Director |
6,000 | $0 | 74,822 (Direct) |
View |
| 2020-08-20 Exercise |
2020-08-21 5:58 pm |
N/A N/A |
FIBROGEN INC | FGEN | Schoeneck James A Director |
6,000 | $5.95 | 74,822 (Direct) |
View |
| 2020-08-11 Exercise |
2020-08-11 4:34 pm |
N/A N/A |
FIBROGEN INC | FGEN | Cotroneo Pat SVP, Finance and CFO |
3,500 | $18 | 293,452 (Direct) |
View |
| 2020-08-07 Exercise |
2020-08-11 4:34 pm |
N/A 2026-02-22 |
FIBROGEN INC | FGEN | Cotroneo Pat SVP, Finance and CFO |
29,804 | $0 | 293,452 (Direct) |
View |
| 2020-08-07 Exercise |
2020-08-11 4:34 pm |
N/A N/A |
FIBROGEN INC | FGEN | Cotroneo Pat SVP, Finance and CFO |
26,304 | $19.39 | 293,452 (Direct) |
View |
| 2020-08-05 Option Award |
2020-08-07 7:50 pm |
N/A 2030-08-05 |
FIBROGEN INC | FGEN | Cravatt Benjamin Director |
20,810 | $0 | 20,810 (Direct) |
View |
| 2020-08-05 Option Award |
2020-08-07 7:45 pm |
N/A 2030-08-05 |
FIBROGEN INC | FGEN | Brennan Aoife Director |
20,810 | $0 | 20,810 (Direct) |
View |
Ownership |
2020-08-07 7:29 pm |
N/A N/A |
FIBROGEN INC | FGEN | Cravatt Benjamin Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2020-08-07 7:25 pm |
N/A N/A |
FIBROGEN INC | FGEN | Brennan Aoife Director |
0 | $0 | 0 (Direct) |
View |